|
231
|
|
|
NADH:ubiquinone oxidoreductase subunit S4 |
AQDQ, CI-18, CI-18 kDa, CI-AQDQ, MC1DN1 |
Brain disease, Colorectal cancer, Developmental coordination disorder, Developmental regression, Gout, Leigh syndrome, Mitochondrial complex deficiency, Mitochondrial disease, Motor skills disorder, Ovarian serous carcinoma, Schizophrenia, Diabetes mellitus, type 2 |
|
232
|
|
|
NADH:ubiquinone oxidoreductase subunit S5 |
CI-15k, CI15K |
|
|
233
|
|
|
NADH:ubiquinone oxidoreductase subunit S6 |
CI-13kA, CI-13kD-A, CI13KDA, MC1DN9 |
|
|
234
|
|
|
NADH:ubiquinone oxidoreductase core subunit S8 |
CI-23k, CI23KD, MC1DN2, TYKY |
|
|
235
|
|
|
NADH:ubiquinone oxidoreductase core subunit V2 |
CI-24k, MC1DN7 |
Bipolar disorder, Cardiomyopathy, Bipolar depression, Epilepsy, Essential tremor, Leigh syndrome, Major depressive disorder, Mitochondrial complex deficiency, Mitochondrial disease, Mitochondrial encephalomyopathy, Parkinson disease, Schizophrenia, Depression |
|
236
|
|
|
NADH:ubiquinone oxidoreductase subunit V3 |
CI-10k, CI-9KD |
|
|
237
|
|
|
NEDD4 E3 ubiquitin protein ligase |
NEDD4-1, RPF1 |
|
|
238
|
|
|
Neural precursor cell expressed, developmentally down-regulated 9 |
CAS-L, CAS2, CASL, CASS2, HEF1 |
Ischemic heart disease, Coronary artery disease, Dental caries, Digestive system disease, Human immunodeficiency virus infection, Hypothyroidism, Multiple sclerosis, Nonalcoholic fatty liver disease, Paralytic strabismus, Prostate cancer, Small cell lung carcinoma, Diabetes mellitus, type 2 |
|
239
|
|
|
Neurofilament medium chain |
NEF3, NF-M, NFM |
|
|
240
|
|
|
Neurofilament heavy chain |
CMT2CC, NFH |
|